Navigation Links
Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target

N: 0in 0in 0pt">Tel: +31-412-663685

Fax: +31 (0) 412 662568 Email address: elina.daamen@organon.com

About Organon
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include immunology and specific areas of oncology. Organon products are distributed in over 100 countries worldwide, of which more than 50 have an Organon subsidiary. Organon is the human healthcare business unit of Akzo Nobel.
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/27/2009)... , SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCal...ystems, Inc. (NYSE: VAR ), a premier supplier of...s, will exhibit its full range of detectors at the...r 29 - December 3, 2009. Varian will also be exhi...es as well as specialized cancer treatment technol...
(Date:11/26/2009)... , JOHANNESBURG, South Africa, Nov. 26 /PRNews...a Company of the Year Award in the Generic Pharmac...Africa Limited. ,, (Logo: http://www.newscom.c...mpany of the Year Award, the following criteria we...ainst key competitors: growth strategy and impleme...
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCa...ding provider of advanced diagnostic and special...today agreements with Roche Diagnostics Corporatio...ted consumables for the veterinary market. ,...00622/HESKALOGO ) ,, "Heska and Roche share the...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3BenefitPackages com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 62094 1BenefitPackages com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 62094 2Computerized order entry decision support systems 3A Effective solution to managing imaging utilization 62091 1Computerized order entry decision support systems 3A Effective solution to managing imaging utilization 62091 2High salt intake linked to strokes and cardiovascular disease 62088 1High salt intake linked to strokes and cardiovascular disease 62088 2
(Date:11/27/2009)...FRANCISCO, Nov. 27 The G...t Blair Lambert, CFO/COO, will present at the NASD...t the May Fair Hotel in London, England, on Wednes... listen to a live broadcast of The Gymboree Corpor... on to www.gymboree.com, click on "Our Company" at...
(Date:11/27/2009)...UTZ SHAMIR, Israel, Nov. 27 /PRNewswire-FirstCall/...( "Shamir" ), a leading provider of innovative pro..., announced today that its board of directors had ...mount of US$ 10 million (approximately NIS 37.62 m...ve rate of exchange), or approximately US$ 0.609 (...
(Date:11/27/2009)...o bring unprecedented medical, economic burdens, s...hDay News) -- The number of people with diabetes i... next 25 years, a new study predicts. , That wo...people with the disease, up from 23.7 million toda...ople with diabetes will triple, the study also war...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
(Date:11/26/2009)... YORK, Nov. 27 With cold and flu s...ploy good practices to control the spread of infec...ctive not only to keep ourselves healthy, but to a...een Finerty, RN, MS, CIC (certified in infection-c...d occupational health at Hospital for Special Surg...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
... in Study Not Atkins Diet , , DENVER, Feb. 27 A ...y titled "Comparison of Weight-Loss Diets with Dif...ates" (Feb. 26, 2009), concluded that reduced-calo...itionals, Inc. ("Atkins"), however, wishes to clar...
...ability of Long Term Care Workforce Put at Risk by...idates Importance of LTC Sector to U.S. Economy, J... conjunction with releasing new national data show... term care leaders expressed alarm that Medicare c...
...versity of Georgia study suggests that health agen...sider untreated surface water as a possible source...ppear in the March issue of the journal Applied a...adic salmonella cases. The team found Salmonella i...
...e following is a statement by Robert Greenstein, E...cy Priorities: , , The President,s budget represe...s in restoring fiscal discipline while addressing ...ularly courageous are several proposals that take ...
...D Health Corp. (Nasdaq: WBMD ) and HLTH Corporat...ves of WebMD are scheduled to participate at the M...rch 3, 2009 at 7:05 p.m. ET. , , Investors, ana...www.wbmd.com (in the Investor Relations section)....
...gery Study Reveals Conclusive Findings , , NEWPOR... cancer diagnosis may find additional cancer in th...ng Breast-Specific Gamma Imaging (BSGI) according ...ite breast in 10.9 percent of newly diagnosed pati...
Other Medicine News:Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 2Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 3Health News:National, State Long Term Care Leaders Express Concern That FY 2010 Medicare Cuts Undermine, Contradict Intent of Economic Stimulus Law 2Health News:National, State Long Term Care Leaders Express Concern That FY 2010 Medicare Cuts Undermine, Contradict Intent of Economic Stimulus Law 3Health News:Study suggests surface water contaminated with salmonella more common than thought 2Health News:Study suggests surface water contaminated with salmonella more common than thought 3Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 2Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 3Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 4Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 2Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 3
... WideBiter Punch series facilitates fast and effec...a smooth, anatomically shaped meniscal rim. The fl...le to access even the tightest joint spaces. Made ...of engineering experience in arthroscopy hand inst...
... WideBiter Punch series facilitates fast and effec...a smooth, anatomically shaped meniscal rim. The fl...le to access even the tightest joint spaces. Made ...of engineering experience in arthroscopy hand inst...
... WideBiter Punch series facilitates fast and effec...a smooth, anatomically shaped meniscal rim. The fl...le to access even the tightest joint spaces. Made ...of engineering experience in arthroscopy hand inst...
... patented ratchet design provides fingertip ratche...ping. , ,The Series I Instrument program offers st...ly low profile, while maintaining strength and dur...pathology in tight joint spaces. Series I instrume...
Medicine Products: